Sector valuations Telix Pharmaceuticals Limited
Equities
TLX
AU000000TLX2
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.70 AUD | +6.56% |
|
+14.71% | +4.46% |
| 03-16 | Telix Pharmaceuticals Refiles NDA for Brain Cancer Imaging Candidate | MT |
| 03-16 | Australian Shares Fall; Orica Signs Settlement Agreement With Ammonium Nitrate Supplier | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -1638.81x | 6.67x | 21.12x | 3.09x | 62.89x | 71.14x | -.--% | 2.62B | ||
| 33.16x | 3.46x | 0.53x | 4.93x | 16.54x | 24.22x | 1.02% | 42.95B | ||
| 52.99x | 6.74x | 0.46x | 4.49x | 30.23x | 38.19x | -.--% | 32.12B | ||
| 52.81x | 2.52x | 0.57x | 10.85x | 30.15x | 38.93x | 0.36% | 29.32B | ||
| 19.99x | 3.59x | 3.85x | 2.36x | 10.19x | 15.44x | -.--% | 27.68B | ||
| -12.93x | 17.51x | -0.45x | 336.77x | -10.96x | -10.87x | -.--% | 19.62B | ||
| 44.75x | 162.28x | -0.2x | 8.4x | 26.33x | 33.36x | -.--% | 14.18B | ||
| 26.53x | 13.22x | 2.23x | 4.22x | 19.21x | 20.14x | -.--% | 12.87B | ||
| 20.04x | 2.27x | 0.54x | 1.86x | 8.14x | 12.53x | 1.23% | 12.39B | ||
| -17.89x | -49.21x | -0.26x | 13.94x | -19.43x | -17.89x | -.--% | 11.95B | ||
| -34.77x | 19.92x | -3.43x | 1396.26x | -37.93x | -35.21x | - | 9.58B | ||
| -31.82x | 21.43x | -2.38x | 6.1x | 150.32x | -295.89x | -.--% | 9.1B | ||
| 20.87x | 2.33x | 0.05x | 4.26x | 11.59x | 14.37x | 0.5% | 8.43B | ||
| -20.24x | 7.56x | -1.71x | 1150.78x | -16.94x | -16.74x | -.--% | 8.49B | ||
| 38.84x | 3.51x | 0.22x | 6.18x | 17.3x | 19.05x | 0.66% | 7.64B | ||
| 19.51x | - | -0.05x | - | - | - | -.--% | 7.48B | ||
| 15.1x | 0.8x | -0.47x | 1.3x | 6.63x | 7.38x | -.--% | 7.45B | ||
| 28.43x | 3.31x | -9.24x | 3.59x | 14.72x | 23.16x | 0.72% | 6.85B | ||
| Average | -76.86x | 13.41x | 0.63x | 174.08x | 18.76x | -3.45x | 0.26% | 15.04B | |
| Weighted average by Cap. | 6.72x | 12.67x | 0.38x | 117.92x | 17.20x | 6.81x | 0.32% |
- Stock Market
- Equities
- TLX Stock
- Sector Telix Pharmaceuticals Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















